{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:44:43Z","timestamp":1787237083482,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministerio de Econom\u00eda, Comercio y Competitividad and Fondo Europeo de Desarrollo Regional","award":["SAF2015-68073-R"],"award-info":[{"award-number":["SAF2015-68073-R"]}]},{"name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades and Fondo Europeo de Desarrollo Regional","award":["RTI2018-097125-B-I00"],"award-info":[{"award-number":["RTI2018-097125-B-I00"]}]},{"name":"Fondo de Investigaciones Sanitarias - Instituto de Salud Carlos III","award":["P17-01401"],"award-info":[{"award-number":["P17-01401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dyskeratosis congenita (DC) is a rare telomere biology disorder, which results in different clinical manifestations, including severe bone marrow failure. To date, the only curative treatment for the bone marrow failure in DC patients is allogeneic hematopoietic stem cell transplantation. However, due to the toxicity associated to this treatment, improved therapies are recommended for DC patients. Here, we aimed at generating DC-like human hematopoietic stem cells in which the efficacy of innovative therapies could be investigated. Because X-linked DC is the most frequent form of the disease and is associated with an impaired expression of\n                    <jats:italic>DKC1<\/jats:italic>\n                    , we have generated DC-like hematopoietic stem cells based on the stable knock-down of\n                    <jats:italic>DKC1<\/jats:italic>\n                    in human CD34\n                    <jats:sup>+<\/jats:sup>\n                    cells with lentiviral vectors encoding for\n                    <jats:italic>DKC1<\/jats:italic>\n                    short hairpin RNAs. At a molecular level,\n                    <jats:italic>DKC1<\/jats:italic>\n                    -interfered CD34\n                    <jats:sup>+<\/jats:sup>\n                    cells showed a decreased expression of\n                    <jats:italic>TERC<\/jats:italic>\n                    , as well as a diminished telomerase activity and increased DNA damage, cell senescence, and apoptosis. Moreover,\n                    <jats:italic>DKC1<\/jats:italic>\n                    -interfered human CD34\n                    <jats:sup>+<\/jats:sup>\n                    cells showed defective clonogenic ability and were incapable of repopulating the hematopoiesis of immunodeficient NSG mice. The development of DC-like hematopoietic stem cells will facilitate the understanding of the molecular and cellular basis of this inherited bone marrow failure syndrome and will serve as a platform to evaluate the efficacy of new hematopoietic therapies for DC.\n                  <\/jats:p>","DOI":"10.1186\/s13287-021-02145-8","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T07:18:20Z","timestamp":1611904700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1"],"prefix":"10.1186","volume":"12","author":[{"given":"Carlos","family":"Carrascoso-Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde A.","family":"Zittersteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pintado-Berninches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fern\u00e1ndez-Varas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luz","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Manguan-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Perona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-0895","authenticated-orcid":false,"given":"Guillermo","family":"Guenechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"18","key":"2145_CR1","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1073\/pnas.86.18.7049","volume":"86","author":"J Meyne","year":"1989","unstructured":"Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG) n among vertebrates. Proc Natl Acad Sci U S A. 1989;86(18):7049\u201353 PubMed PMID: 2780561. Pubmed Central PMCID: PMC297991.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2145_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-12-397898-1.00002-5","volume":"125","author":"SA Savage","year":"2014","unstructured":"Savage SA. Human telomeres and telomere biology disorders. Prog Mol Biol Transl Sci. 2014;125:41\u201366 PubMed PMID: 24993697.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"2145_CR3","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1172\/JCI84547","volume":"126","author":"M Jones","year":"2016","unstructured":"Jones M, Bisht K, Savage SA, Nandakumar J, Keegan CE, Maillard I. The shelterin complex and hematopoiesis. J Clin Invest. 2016;126(5):1621\u20139 PubMed PMID: 27135879. Pubmed Central PMCID: PMC4855927.","journal-title":"J Clin Invest"},{"issue":"2 Pt 1","key":"2145_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","volume":"43","author":"CW Greider","year":"1985","unstructured":"Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43(2 Pt 1):405\u201313 PubMed PMID: 3907856.","journal-title":"Cell."},{"issue":"4","key":"2145_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.febslet.2004.11.036","volume":"579","author":"EH Blackburn","year":"2005","unstructured":"Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005;579(4):859\u201362 PubMed PMID: 15680963.","journal-title":"FEBS Lett"},{"issue":"5820","key":"2145_CR6","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1126\/science.1138596","volume":"315","author":"SB Cohen","year":"2007","unstructured":"Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science. 2007;315(5820):1850\u20133 PubMed PMID: 17395830.","journal-title":"Science."},{"issue":"2","key":"2145_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1399-0004.2007.00923.x","volume":"73","author":"M Kirwan","year":"2008","unstructured":"Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet. 2008;73(2):103\u201312 PubMed PMID: 18005359.","journal-title":"Clin Genet"},{"issue":"18","key":"2145_CR8","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","volume":"124","author":"DM Townsley","year":"2014","unstructured":"Townsley DM, Dumitriu B, Young NS. Bone marrow failure and the telomeropathies. Blood. 2014;124(18):2775\u201383 PubMed PMID: 25237198. Pubmed Central PMCID: PMC4215309.","journal-title":"Blood."},{"key":"2145_CR9","doi-asserted-by":"crossref","unstructured":"Dokal I, Vulliamy T, Mason P, Bessler M. Clinical utility gene card for: dyskeratosis congenita - update 2015. Eur J Hum Genet. 2015;23(4) PubMed PMID: 25182133. Pubmed Central PMCID: PMC4667501.","DOI":"10.1038\/ejhg.2014.170"},{"issue":"12","key":"2145_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ajh.24552","volume":"91","author":"N Perdigones","year":"2016","unstructured":"Perdigones N, Perin JC, Schiano I, Nicholas P, Biegel JA, Mason PJ, et al. Clonal hematopoiesis in patients with dyskeratosis congenita. Am J Hematol. 2016;91(12):1227\u201333 PubMed PMID: 27622320. Pubmed Central PMCID: PMC5118079.","journal-title":"Am J Hematol"},{"key":"2145_CR11","volume-title":"Telomere - A Complex End of a Chromosome","author":"R Perona","year":"2016","unstructured":"Perona R, Iarriccio L, Pintado-Berninches L, Rodriguez-Centeno J, Manguan-Garcia C, Garcia E, et al. Molecular diagnosis and precision therapeutic approaches for telomere biology disorders. In: Larramendy ML, editor. Telomere - A Complex End of a Chromosome. Rijeka: InTech; 2016. p. Ch. 05."},{"issue":"2","key":"2145_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","volume":"54","author":"SA Savage","year":"2017","unstructured":"Savage SA, Dufour C. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia. Semin Hematol. 2017;54(2):105\u201314 PubMed PMID: 28637614.","journal-title":"Semin Hematol"},{"issue":"8","key":"2145_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3324\/haematol.2010.025619","volume":"95","author":"I Dokal","year":"2010","unstructured":"Dokal I, Vulliamy T. Inherited bone marrow failure syndromes. Haematologica. 2010;95(8):1236\u201340 PubMed PMID: 20675743. Pubmed Central PMCID: PMC2913069.","journal-title":"Haematologica."},{"issue":"50","key":"2145_CR14","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.1038\/sj.onc.1205969","volume":"21","author":"J He","year":"2002","unstructured":"He J, Navarrete S, Jasinski M, Vulliamy T, Dokal I, Bessler M, et al. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene. 2002;21(50):7740\u20134 PubMed PMID: 12400016.","journal-title":"Oncogene."},{"issue":"4","key":"2145_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1073\/pnas.0807057106","volume":"106","author":"RT Calado","year":"2009","unstructured":"Calado RT, Regal JA, Hills M, Yewdell WT, Dalmazzo LF, Zago MA, et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A. 2009;106(4):1187\u201392 PubMed PMID: 19147845. Pubmed Central PMCID: PMC2627806.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2145_CR16","first-page":"157","volume":"5","author":"MS Fernandez Garcia","year":"2014","unstructured":"Fernandez Garcia MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med. 2014;5:157\u201367 PubMed PMID: 25170286. Pubmed Central PMCID: PMC4145822.","journal-title":"J Blood Med"},{"issue":"7","key":"2145_CR17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","volume":"22","author":"P Barbaro","year":"2016","unstructured":"Barbaro P, Vedi A. Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature. Biol Blood Marrow Transplant. 2016;22(7):1152\u20138 PubMed PMID: 26968789.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2145_CR18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/s41591-019-0550-z","volume":"25","author":"P Rio","year":"2019","unstructured":"Rio P, Navarro S, Wang W, Sanchez-Dominguez R, Pujol RM, Segovia JC, et al. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia. Nat Med. 2019;25(9):1396\u2013401 PubMed PMID: 31501599.","journal-title":"Nat Med"},{"issue":"13","key":"2145_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1101\/gad.1695808","volume":"22","author":"C Autexier","year":"2008","unstructured":"Autexier C. POT of gold: modeling dyskeratosis congenita in the mouse. Genes Dev. 2008;22(13):1731\u20136 PubMed PMID: 18593874. Pubmed Central PMCID: PMC2732423.","journal-title":"Genes Dev"},{"issue":"4","key":"2145_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbadis.2009.01.010","volume":"1792","author":"M Kirwan","year":"2009","unstructured":"Kirwan M, Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta. 2009;1792(4):371\u20139 PubMed PMID: 19419704.","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"2145_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1101\/gad.1679208","volume":"22","author":"D Hockemeyer","year":"2008","unstructured":"Hockemeyer D, Palm W, Wang RC, Couto SS, de Lange T. Engineered telomere degradation models dyskeratosis congenita. Genes Dev. 2008;22(13):1773\u201385.","journal-title":"Genes Dev"},{"key":"2145_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/990141","volume":"402","author":"JR Mitchell","year":"1999","unstructured":"Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551 12\/02\/online.","journal-title":"Nature"},{"issue":"5","key":"2145_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/jmg.2010.085100","volume":"48","author":"EM Parry","year":"2011","unstructured":"Parry EM, Alder JK, Lee SS, Phillips JA 3rd, Loyd JE, Duggal P, et al. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J Med Genet. 2011;48(5):327\u201333 PubMed PMID: 21415081. Pubmed Central PMCID: PMC3088476.","journal-title":"J Med Genet"},{"issue":"3","key":"2145_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/MMBR.66.3.407-425.2002","volume":"66","author":"YS Cong","year":"2002","unstructured":"Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66(3):407\u201325.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"13","key":"2145_CR25","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1182\/blood-2004-05-1829","volume":"104","author":"A Marrone","year":"2004","unstructured":"Marrone A, Stevens D, Vulliamy T, Dokal I, Mason PJ. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood. 2004;104(13):3936\u201342.","journal-title":"Blood."},{"issue":"9","key":"2145_CR26","first-page":"4523","volume":"111","author":"D Frederick","year":"2008","unstructured":"Frederick D, Goldman GA, Al J, Klingelhutz MH, Cooper SR, Hamilton WS, Schlueter AJ, Lambie K, Connie J. Eaves and Peter M. Lansdorp. Characteristics of primitive hematopoietic cells from patients with Dyskeratosis congenita. Hematopoiesis and Stem Cells. 2008;111(9):4523\u201331.","journal-title":"Hematopoiesis and Stem Cells"},{"issue":"13","key":"2145_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1182\/blood-2017-03-774174","volume":"130","author":"P Rio","year":"2017","unstructured":"Rio P, Navarro S, Guenechea G, Sanchez-Dominguez R, Lamana ML, Yanez R, et al. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34(+) cells from Fanconi anemia patients. Blood. 2017;130(13):1535\u201342 PubMed PMID: 28801449.","journal-title":"Blood."},{"issue":"5","key":"2145_CR28","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.celrep.2013.04.030","volume":"3","author":"C Bellodi","year":"2013","unstructured":"Bellodi C, McMahon M, Contreras A, Juliano D, Kopmar N, Nakamura T, et al. H\/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep. 2013;3(5):1493\u2013502.","journal-title":"Cell Rep"},{"issue":"5","key":"2145_CR29","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1182\/blood-2007-04-083261","volume":"111","author":"R Machado-Pinilla","year":"2008","unstructured":"Machado-Pinilla R, Sanchez-Perez I, Murguia JR, Sastre L, Perona R. A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells. Blood. 2008;111(5):2606\u201314 PubMed PMID: 18057229.","journal-title":"Blood."},{"issue":"11","key":"2145_CR30","doi-asserted-by":"publisher","first-page":"e0142980","DOI":"10.1371\/journal.pone.0142980","volume":"10","author":"L Iarriccio","year":"2015","unstructured":"Iarriccio L, Manguan-Garcia C, Pintado-Berninches L, Mancheno JM, Molina A, Perona R, et al. GSE4, a small dyskerin- and GSE24.2-related peptide, induces telomerase activity, cell proliferation and reduces DNA damage, oxidative stress and cell senescence in dyskerin mutant cells. PloS one. 2015;10(11):e0142980 PubMed PMID: 26571381. Pubmed Central PMCID: PMC4646510.","journal-title":"PloS one"},{"issue":"7","key":"2145_CR31","doi-asserted-by":"publisher","first-page":"e101424","DOI":"10.1371\/journal.pone.0101424","volume":"9","author":"C Manguan-Garcia","year":"2014","unstructured":"Manguan-Garcia C, Pintado-Berninches L, Carrillo J, Machado-Pinilla R, Sastre L, Perez-Quilis C, et al. Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells. PloS one. 2014;9(7):e101424 PubMed PMID: 24987982. Pubmed Central PMCID: 4079255.","journal-title":"PloS one"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-021-02145-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T07:25:37Z","timestamp":1611905137000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2145"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02145-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-26927\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-26927\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-26927\/v3","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human cord blood samples from healthy donors were kindly provided by the <i>Centro de Transfusi\u00f3n de la Comunidad de Madrid<\/i> under the approval of its IRB and in accordance with the Helsinki Declaration. In all instances, informed consents were previously signed by the donors. All experimental procedures involving mice were conducted at the CIEMAT animal facility (registration number 28079-21 A) and were approved by the Animal Welfare Body of this institution. This project was authorized by the competent authorities of the <i>Comunidad de Madrid<\/i>, under the registration number PROEX-70\/15 fulfilling Spanish and European legislation (Spanish RD 53\/2013 and Law 6\/2013 in compliance with the European Directive 2010\/63\/EU about the use and protection of vertebrate mammals used for experimentation and other scientific purposes).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing, neither financial nor non-financial, interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}